KNTE
Price
$2.66
Change
-$0.00 (-0.00%)
Updated
Mar 28, 6:59 PM EST
41 days until earnings call
MBIO
Price
$1.04
Change
+$0.06 (+6.12%)
Updated
Mar 28, 6:59 PM EST
Ad is loading...

Compare trend and price KNTE vs MBIO

Header iconKNTE vs MBIO Comparison
Open Charts KNTE vs MBIOBanner chart's image
Kinnate Biopharma
Price$2.66
Change-$0.00 (-0.00%)
Volume$96.73K
CapitalizationN/A
Mustang Bio
Price$1.04
Change+$0.06 (+6.12%)
Volume$27.82K
CapitalizationN/A
View a ticker or compare two or three
KNTE vs MBIO Comparison Chart

Loading...

KNTEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MBIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
KNTE vs. MBIO commentary
Mar 29, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KNTE is a Buy and MBIO is a Buy.

COMPARISON
Comparison
Mar 29, 2024
Stock price -- (KNTE: $2.65 vs. MBIO: $1.04)
Brand notoriety: KNTE and MBIO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KNTE: 89% vs. MBIO: 28%
Market capitalization -- KNTE: $124.99M vs. MBIO: $10.81M
KNTE [@Biotechnology] is valued at $124.99M. MBIO’s [@Biotechnology] market capitalization is $10.81M. The market cap for tickers in the [@Biotechnology] industry ranges from $570.99B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KNTE’s FA Score shows that 1 FA rating(s) are green whileMBIO’s FA Score has 0 green FA rating(s).

  • KNTE’s FA Score: 1 green, 4 red.
  • MBIO’s FA Score: 0 green, 5 red.
According to our system of comparison, KNTE is a better buy in the long-term than MBIO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KNTE’s TA Score shows that 6 TA indicator(s) are bullish while MBIO’s TA Score has 5 bullish TA indicator(s).

  • KNTE’s TA Score: 6 bullish, 3 bearish.
  • MBIO’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, KNTE is a better buy in the short-term than MBIO.

Price Growth

KNTE (@Biotechnology) experienced а 0.00% price change this week, while MBIO (@Biotechnology) price change was -7.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.98%. For the same industry, the average monthly price growth was +8.91%, and the average quarterly price growth was +90.55%.

Reported Earning Dates

KNTE is expected to report earnings on May 09, 2024.

MBIO is expected to report earnings on May 12, 2023.

Industries' Descriptions

@Biotechnology (+4.98% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for KNTE with price predictions.
OPEN
A.I.dvisor published
a Summary for MBIO with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KNTE($125M) has a higher market cap than MBIO($10.8M). KNTE YTD gains are higher at: 11.814 vs. MBIO (-22.963). MBIO has higher annual earnings (EBITDA): -48.06M vs. KNTE (-131.8M). KNTE has more cash in the bank: 168M vs. MBIO (6.23M). MBIO has less debt than KNTE: MBIO (2.5M) vs KNTE (3.38M). KNTE (0) and MBIO (0) have equivalent revenues.
KNTEMBIOKNTE / MBIO
Capitalization125M10.8M1,157%
EBITDA-131.8M-48.06M274%
Gain YTD11.814-22.963-51%
P/E RatioN/AN/A-
Revenue00-
Total Cash168M6.23M2,695%
Total Debt3.38M2.5M135%
FUNDAMENTALS RATINGS
MBIO: Fundamental Ratings
MBIO
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
95
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KNTEMBIO
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
80%
MACD
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 1 day ago
85%
Declines
ODDS (%)
Bearish Trend 15 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
Bullish Trend 1 day ago
71%
N/A
View a ticker or compare two or three
Ad is loading...
KNTEDaily Signal changed days agoGain/Loss if shorted
 
Show more...
MBIODaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RIGKX14.13N/A
N/A
Victory RS International R
CMRCX9.85N/A
N/A
Calamos Merger Arbitrage C
FSATX15.13N/A
N/A
Fidelity Advisor Asset Manager 60% M
GMEZX12.10N/A
N/A
GuideStone Funds Impact Equity Inv
WPCSX50.36-0.01
-0.02%
AB Concentrated Growth C

KNTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, KNTE has been loosely correlated with RLAY. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if KNTE jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KNTE
1D Price
Change %
KNTE100%
-0.38%
RLAY - KNTE
43%
Loosely correlated
+1.72%
CRSP - KNTE
37%
Loosely correlated
-2.85%
LYEL - KNTE
36%
Loosely correlated
+9.31%
GOSS - KNTE
34%
Loosely correlated
+0.43%
GLUE - KNTE
33%
Poorly correlated
+0.14%
More

MBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MBIO has been loosely correlated with MDGL. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if MBIO jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MBIO
1D Price
Change %
MBIO100%
+10.64%
MDGL - MBIO
50%
Loosely correlated
+3.18%
ORMP - MBIO
44%
Loosely correlated
+3.55%
AXON - MBIO
40%
Loosely correlated
-0.98%
CYTK - MBIO
38%
Loosely correlated
-1.82%
CRSP - MBIO
33%
Loosely correlated
-2.85%
More